Role of intralesioal Vitamin D in treatment of cutaneous warts

---

Original Article

Author Details : Noreen Munshi*, Krishnendra Varma

Volume : 8, Issue : 4, Year : 2022

Article Page : 248-251

https://doi.org/10.18231/j.ijced.2022.050

Suggest article by email

Get Permission

---

Abstract

Background: The majority of treatments for skin warts include destructive techniques like electrocautery and cryotherapy. These techniques of treatment frequently result in recurrence and scarring. Examining the safety and efficiency of intralesional vitamin D3 injection in cutaneous warts is the goal of this study.
Materials and Methods: Total 50 people with recalcitrant warts of different dimensions, frequencies, and longevity participated in the study. 0.2 to 0.5 ml of vitamin D3 (600,000 IU, 15 mg/ml) were injected into the bases of warts. A maximum of 5 warts were administered per session, with sessions occurring every 2 weeks till the warts vanished, or for a total of 3 sessions. Following the final injection, individuals were monitored for six months to look for any recurrence.
Results: The trial was completed by 50 patients. Out of 50 patients, 35 (or 70%) showed a complete reaction, five (10%) showed a partial response, and ten (10%) showed no response. In every case, the distant warts completely disappeared.
Conclusion: A safe, effective, and affordable therapy option for resistant warts is intralesional vitamin D3.
 

Keywords: Vitamin D3, Intralesional treatment, Cutaneous warts

How to cite : Munshi N, Varma K, Role of intralesioal Vitamin D in treatment of cutaneous warts. IP Indian J Clin Exp Dermatol 2022;8(4):248-251

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.